Sempra
SRE - NYSE - $94.37 ▼ -%0.01
-
Earnings Thu 7 May
Note: this preview was published before the 2026-05-07 earnings report. Results have since been released — verify against the latest filings.

Sempra opens the
books on Thursday evening.

5 analysts' median target is $105[FMP target], stock is $94, +11.3% upside potential. After Q4 +3.2% EPS beat[FMP earnings], the stock moved +1.1%.

summary below
Quick Take - in 40 seconds
C+
HOLD Council 1/6 - Moonshot 33

C+ = MoonshotScore 33[9-pillar formula] + Council 1/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q4 consensus: revenue $4.1B[FMP est], EPS $1.48[FMP est]. 5 consecutive quarters of beat[FMP earnings].

$1.48 EPS Estimate Last year $1.28 - +3% YoY YoY
5 Beat Streak Expectations beaten consecutively for the last 5 quarters

Q4 EPS +3.2% beat[FMP] but the stock +1.1% D+1[FMP D+1]. Karen L. Sedgwick promised $3.4B CapEx + a sequential decline in Q4 during the Q4 earnings call[Karen L. Sedgwick capex transcript].

Watchlist

5 metrics stand out this quarter.

2026 Expectation / Guide

2030 Eps Outlook

2030_eps_outlook

Sempra is affirming its full year 2026 adjusted earnings per share guidance range of $4.80 to $5.30, introducing its full year 2027 EPS guidance range of $5.10 to $5.70, and issuing a 2030 EPS outlook of $6.70 to $7.50.

"Today, Sempra is affirming our full year 2026 adjusted earnings per share guidance range of $4.80 to $5.30, introducing our full year 2027 EPS guidance range of $5.10 to $5.70, and issuing a 2030 EPS outlook of $6.70 to $7.50. With today's update, we believe we have one of the highest projected growth rates in the sector, and our 2030 outlook shows that our strong long-term growth expectations continue through the end of the decade."

- Karen L. Sedgwick, Executive Vice President and Chief Financial Officer - Q4 FY25 Earnings Call - February 26, 2026
18% Investor Focus

Sempra Texas Rate Base Growth

sempra_texas_rate_base_growth

Sempra Texas rate base is projected to grow at a remarkable 18% CAGR over the plan period.

"Sempra Texas rate base is projected to grow at a remarkable 18% CAGR over the plan period"

- Karen L. Sedgwick, Executive Vice President and Chief Financial Officer - Q4 FY25 Earnings Call - February 26, 2026
70% Risk Indicator

Oncor Transmission Capex

oncor_transmission_capex

Nearly 70% of Oncor's planned CapEx is dedicated towards transmission.

"Consequently, nearly 70% of Oncor's planned CapEx is dedicated towards transmission."

- Karen L. Sedgwick, Executive Vice President and Chief Financial Officer - Q4 FY25 Earnings Call - February 26, 2026
45% Investor Focus

Sempra Infrastructure Sale

sempra_infrastructure_sale

The sale of a 45% stake in Sempra Infrastructure Partners for $10 billion implies over a $22 billion equity value, and the transaction is expected to close in 2026.

"In September, we announced the sale of a 45% stake in Sempra Infrastructure Partners for $10 billion, implying over a $22 billion equity value. We are pleased to recognize the significant value created on behalf of our shareholders at an attractive multiple, and we continue to expect to close that transaction in 2026, subject to closing conditions."

- Jeffrey Walker Martin, Chairman and Chief Executive Officer - Q4 FY25 Earnings Call - February 26, 2026
$65 billion Investor Focus

2026 2030 Capital Plan

2026-2030_capital_plan

Sempra announced a record capital plan of $65 billion for the 2026 to 2030 period, with 95% targeted for utility investments.

"We are excited to announce our 2026 to 2030 capital plan totaling $65 billion, an increase of $9 billion over last year's plan. In support of our mission, 95% of Sempra's overall capital program is targeted for utility investments."

- Karen L. Sedgwick, Executive Vice President and Chief Financial Officer - Q4 FY25 Earnings Call - February 26, 2026

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 1 / 6 Bullish

6 investor frameworks. 1 bullish (Ray Dalio), 1 bearish (Ken Griffin), 4 neutral (Jim Simons, Klarman, Buffett, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +11.3%
Ken Griffin flow - 50d MA below
Jim Simons quant - RSI 49
Klarman value - target upside +11.3%
Buffett quality - ROE score 2/5
Munger valuation - target upside +11.3%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthWeak
Margin of SafetyModerate
Interest CoverageAdequate
ROIC vs WACCTight
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
48.9 RSI 48.9 balanced, 50d below
MACD
-0.70 price below 50d - resistance dominant
50d MA
$95 stock 0.7% below - short-term resistance
200d MA
$90 stock 5.4% above - long-term support
Volume (10d)
-30% decrease - low participation
Resistance
$105
Analyst median target - upgrade trigger if broken
Current
$94
Pre-earnings position
Support
$76
Invalidation - close below this is a technical breakdown
Pattern
Range
$76-$105 band - earnings breakout/breakdown trigger

Past Performance

Sempra's last 8 quarters: 5 consecutive beats.

BEAT
Q1 FY25
$1.44 vs $1.32 est - -0.5%
BEAT
Q2 FY25
$0.89 vs $0.85 est - -1.1%
BEAT
Q3 FY25
$1.11 vs $0.91 est - +0.4%
BEAT
Q4 FY25
$1.28 vs $1.24 est - +1.1%

Q4 (February 26, 2026): EPS $1.28 vs $1.24 est[FMP], +3.2% beat. D+1 movement: +1.1%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $1.44 (no guidance)

Q4: EPS $1.28 vs $1.24 beat[FMP], stock +1.1% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q4 earnings call.

CapEx shock

Q4 CapEx $3.4B[FMP cashflow]. Q4 op margin 29.3%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q4 EPS > $1.48 + CapEx discipline
Threshold: EPS > $1.48[FMP est].
Target: Break above median target $105[FMP target]; high target $118[FMP] upper bound.
Scenario B - In-Line
EPS approx $1.48 + CapEx < $3.4B
Threshold: EPS approx $1.48[FMP est], Q4 CapEx < $3.4B[FMP].
Target: Consolidation in the band between current $94[FMP] and median $105[FMP].
Scenario C - Miss
EPS < $1.44 or CapEx >= $3.4B
Threshold: EPS < $1.44[FMP estx0.97].
Target: Current $94 below SMA200 $90[FMP], if rejection continues, $76[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 5 analysts say?

Wall Street Consensus
$105
12-month median target price (+11.3% upside potential)
14
BUY
5
HOLD
0
SELL
Risk Management
$76
Invalidation level - critical support threshold
$95 - 50-day MA (below, -0.7%)
$90 - 200-day MA (above, +5.4%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - SRE Q4 FY26
C+

You read it in 5 minutes. When the numbers come out on Thursday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Thursday evening. The framework is ready on this page: Q4 EPS threshold $1.48[FMP], CapEx threshold "below $3.4B"[Karen L. Sedgwick]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

May 7, 2026EARNINGSQ4 FY26 results (after market close) + earnings call
May 8, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Jun 21, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Aug 7, 2026EARNINGSQ1 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the SRE earnings preview cover?

This SRE (SRE) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in SRE earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.